UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 16, 2010
Date of Report (date of earliest event reported)
MICROFLUIDICS INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
Commission file number 0-11625
DELAWARE |
|
04-2793022 |
(State or Other |
|
(I.R.S. |
30 Ossippe Road, |
|
|
Newton, MA |
|
02464 |
(Address of Principal |
|
(Zip Code) |
(617) 969-5452
(Registrants Telephone No., including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 16, 2010, Microfluidics International Corporation (the Company) held its 2010 Annual Meeting of Stockholders. At the meeting, the Companys stockholders elected each of the six nominees for directors and ratified the appointment of Markum LLP as the Companys independent registered public accounting firm for the year ending December 31, 2010. The Companys stockholders did not approve the amendments to the 2006 Stock Plan. The voting results are indicated below:
(1) Election of six directors for a term of one year each, to serve until their successors have been duly elected and have qualified or until their earlier removal and resignation:
Director |
|
For |
|
Against |
|
Abstain |
|
Broker-Non Votes |
|
Michael C. Ferrara |
|
3,934,122 |
|
1,481,755 |
|
16,465 |
|
3,915,473 |
|
George Uveges |
|
3,526,503 |
|
1,889,289 |
|
16,550 |
|
3,915,473 |
|
Leo Pierre Roy |
|
3,377,108 |
|
2,036,684 |
|
18,550 |
|
3,915,473 |
|
Eric G. Walters |
|
3,898,135 |
|
1,515,657 |
|
18,550 |
|
3,915,473 |
|
Henry Kay |
|
3,986,620 |
|
1,430,172 |
|
15,550 |
|
3,915,473 |
|
Stephen J. Robinson |
|
3,983,635 |
|
1,433,157 |
|
15,550 |
|
3,915,473 |
|
(2) To amend the 2006 Stock Plan to increase the number of shares of common stock authorized for issuance under the 2006 Stock Plan as well as to make certain other changes described in the proxy statement.
For |
|
Against |
|
Abstain |
|
Broker-NonVotes |
|
1,163,621 |
|
4,038,671 |
|
230,050 |
|
3,915,473 |
|
(3) Ratification of the appointment of Markum LLP as the Companys independent registered public accounting firm for the year ending December 31, 2010:
For |
|
Against |
|
Abstain |
|
9,330,901 |
|
33,866 |
|
13,048 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MICROFLUIDICS INTERNATIONAL CORPORATION |
|
|
(Registrant) |
|
|
|
|
June 18, 2010 |
|
|
|
By: |
/s/ Peter Byczko |
|
Peter Byczko |
|
|
Vice President of Finance and Chief Accounting Officer |